Unión Europea - español - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artritis, reumatoide - inmunosupresores - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant puede usarse como monoterapia o en combinación con metotrexato. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

tecnofarma s.a. - baricitinib - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

tecnofarma s.a. - baricitinib - sin formulas

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

eli lilly and company estados unidos - baricitinib (1) 4mg - comprimidos recubiertos - cada comprimido recubierto contine: baricitinib (1) 4mg

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

eli lilly and company estados unidos - baricitinib 2mg - comprimidos recubiertos - cada comprimido recubierto contiene: baricitinib 2 mg

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

eli lilly interamerica inc. sucursal peruana - comprimido recubierto - por comprimido - baricitinib

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

eli lilly interamerica inc. sucursal peruana - comprimido recubierto - por comprimido - baricitinib

Unión Europea - español - EMA (European Medicines Agency)

angelini pharma s.p.a - cenobamate - epilepsia - los antiepilépticos, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.